Disclaimer: You are now leaving www.beiresources.org and are going to a website that is not operated by BEI Resources. We are not responsible for the content or availability of linked sites.
ABOUT THIRD PARTY LINKS ON OUR SITE: BEI Resources offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links, you will leave the BEI Resources website and will be redirected to another site. These sites are not under the control of BEI Resources. BEI Resources is not responsible for the content of linked third party websites. We are neither an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information. Please read third party privacy and security policies closely as these may be different than BEI Resources policies. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.
Are you sure you would like to be notified when the item is available?
This antibody is purified by protein A affinity chromatography and maps to the gp120 CD4 binding site.
Note: The user should determine the optimal concentration for any application.
Each vial of ARP-2640 lot 180012 contains 100 µg of purified antibody at a concentration of approximately 9.6 mg/mL in PBS.
Please refer to the attached file(s) for more information.
Note: Avoid freeze-thaw cycles as reagent degradation may result.
Please include references cited below in publications.
Burton, D. R., et al. “A Large Array of Human Monoclonal Antibodies to HIV-1 from Combinatorial Libraries of Asymptomatic Seropositive Individuals.” Proc. Natl. Acad. Sci. USA 88 (1991): 10134-10137. PubMed: 1719545. Barbas, C. F. III, et al. “Recombinant Human Fab Fragments Neutralize Human Type 1 Immunodeficiency Virus in Vitro.” Proc. Natl. Acad. Sci. USA 89 (1992): 9339-9343. PubMed: 1384050. Roben, P., et al. “Recognition Properties of a Panel of Human Recombinant Fab Fragments to the CD4 Binding Site of gp120 that Show Differing Abilities to Neutralize Human Immunodeficiency Virus Type 1”. J. Virol. 68 (1994): 4821-4828. PubMed: 7518527. Burton, D. R., et al. “Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody.” Science 266 (1994): 1024-1027. PubMed: 7973652.
When applying for permits and forms please:
Do NOT reference BEI Resources or ATCC Catalog Numbers in the Material Description fields found on the permits and/or forms.
Make sure your name and address on the permit applications and/or forms are exactly as they appear on your BEI Resources registration.
Information about permits is provided as a courtesy to BEI Resources customers. While we use reasonable efforts to include accurate and up-to-date information on this page, we make no warranties or representation as to its accuracy.
For more information on the necessary compliance requirements associated with the biological materials provided by BEI Resources, please select this link: Compliance Requirements.